Carl DeSelm
Overview
Explore the profile of Carl DeSelm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
338
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sridaran D, Bradshaw E, DeSelm C, Pachynski R, Mahajan K, Mahajan N
Cell Rep Med
. 2023 Sep;
4(10):101199.
PMID: 37738978
Cancer immunotherapy has gained traction in recent years owing to remarkable tumor clearance in some patients. Despite the notable success of immune checkpoint blockade (ICB) in multiple malignancies, engagement of...
2.
Schiff J, Chin R, Roy A, Mahapatra L, Stowe H, Andruska N, et al.
Pract Radiat Oncol
. 2022 May;
12(5):e406-e414.
PMID: 35526826
Purpose: Nonoperative management with short-course radiation therapy (SCRT) as a component of definitive therapy for oligometastatic rectal cancer has not been previously reported. This single-institution retrospective analysis evaluates treatment with...
3.
DeSelm C
Br J Radiol
. 2021 Aug;
94(1127):20210098.
PMID: 34375124
Radiation therapy has the potential to modulate the immune system in a variety of ways, and given the critical role of the immune system in cancer elimination, it is becoming...
4.
Imber B, Sadelain M, DeSelm C, Batlevi C, Brentjens R, Dahi P, et al.
Br J Haematol
. 2020 Mar;
190(1):45-51.
PMID: 32135029
Radiotherapy is potentially an important salvage strategy post-chimeric antigen receptor T cell therapy (CART), but limited data exist. We reviewed 14 patients treated with salvage radiation post-CART progression (SRT). Most...
5.
DeSelm C, Palomba M, Yahalom J, Hamieh M, Eyquem J, Rajasekhar V, et al.
Mol Ther
. 2018 Nov;
26(11):2542-2552.
PMID: 30415658
CD19 chimeric antigen receptors (CARs) have demonstrated great efficacy against a range of B cell malignancies. However, antigen escape and, more generally, heterogeneous antigen expression pose a challenge to applying...
6.
DeSelm C, Yang T, Cahlon O, Tisnado J, Khan A, Gillespie E, et al.
Int J Radiat Oncol Biol Phys
. 2018 Oct;
103(3):583-591.
PMID: 30367906
Purpose: The primary goal was to map the anatomic pattern of isolated nodal recurrences (NR) in the supraclavicular (SCV), axillary, and internal mammary nodes (IMNs) in patients with breast cancer...
7.
LaPlant Q, DeSelm C, Lockney N, Hsieh J, Yamada Y
Pract Radiat Oncol
. 2017 May;
7(6):396-399.
PMID: 28551390
No abstract available.
8.
Romesser P, Cahlon O, Scher E, Hug E, Sine K, DeSelm C, et al.
Int J Radiat Oncol Biol Phys
. 2016 Apr;
95(1):386-395.
PMID: 27084656
Purpose: Reirradiation therapy (re-RT) is the only potentially curative treatment option for patients with locally recurrent head and neck cancer (HNC). Given the significant morbidity with head and neck re-RT,...
9.
Setton J, Han J, Kannarunimit D, Wuu Y, Rosenberg S, DeSelm C, et al.
Oral Oncol
. 2015 Dec;
53:67-73.
PMID: 26675283
Background: We report treatment outcomes for a large non-endemic cohort of patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT) and chemotherapy. Methods: We identified 177 consecutive patients with newly...
10.
Kramer K, Pandit-Taskar N, Zanzonico P, Wolden S, Humm J, DeSelm C, et al.
J Neurooncol
. 2015 May;
123(2):245-9.
PMID: 25944385
Radionecrosis is a potentially devastating complication of external beam radiotherapy (XRT). Intraventricular compartmental radioimmunotherapy (cRIT) using (131)I-3F8 or (131)I-8H9 can eradicate malignant cells in the CSF. The incidence of radionecrosis...